215 related articles for article (PubMed ID: 19371356)
1. Pi3K-mTOR signaling and AMOG expression in epilepsy-associated glioneuronal tumors.
Boer K; Troost D; Timmermans W; van Rijen PC; Spliet WG; Aronica E
Brain Pathol; 2010 Jan; 20(1):234-44. PubMed ID: 19371356
[TBL] [Abstract][Full Text] [Related]
2. Expression patterns of AMOG in developing human cortex and malformations of cortical development.
Boer K; Spliet WG; van Rijen PC; Jansen FE; Aronica E
Epilepsy Res; 2010 Sep; 91(1):84-93. PubMed ID: 20656459
[TBL] [Abstract][Full Text] [Related]
3. Alterations of phosphatidylinositol 3-kinase pathway components in epilepsy-associated glioneuronal lesions.
Schick V; Majores M; Koch A; Elger CE; Schramm J; Urbach H; Becker AJ
Epilepsia; 2007; 48 Suppl 5():65-73. PubMed ID: 17910583
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD34 as a novel marker for glioneuronal lesions associated with chronic intractable epilepsy.
Deb P; Sharma MC; Tripathi M; Sarat Chandra P; Gupta A; Sarkar C
Neuropathol Appl Neurobiol; 2006 Oct; 32(5):461-8. PubMed ID: 16972880
[TBL] [Abstract][Full Text] [Related]
5. Akt-dependent cell size regulation by the adhesion molecule on glia occurs independently of phosphatidylinositol 3-kinase and Rheb signaling.
Scheidenhelm DK; Cresswell J; Haipek CA; Fleming TP; Mercer RW; Gutmann DH
Mol Cell Biol; 2005 Apr; 25(8):3151-62. PubMed ID: 15798201
[TBL] [Abstract][Full Text] [Related]
6. BRAF V600E mutation is associated with mTOR signaling activation in glioneuronal tumors.
Prabowo AS; Iyer AM; Veersema TJ; Anink JJ; Schouten-van Meeteren AY; Spliet WG; van Rijen PC; Ferrier CH; Capper D; Thom M; Aronica E
Brain Pathol; 2014 Jan; 24(1):52-66. PubMed ID: 23941441
[TBL] [Abstract][Full Text] [Related]
7. [Expression of PI3K pathway proteins in refractory epilepsy associated with cortical malformation development].
Ni HC; Sun FH; Piao YS; Ma XL; Lu DH
Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):391-5. PubMed ID: 22932407
[TBL] [Abstract][Full Text] [Related]
8. Alterations in BRAF gene, and enhanced mTOR and MAPK signaling in dysembryoplastic neuroepithelial tumors (DNTs).
Kakkar A; Majumdar A; Kumar A; Tripathi M; Pathak P; Sharma MC; Suri V; Tandon V; Chandra SP; Sarkar C
Epilepsy Res; 2016 Nov; 127():141-151. PubMed ID: 27599148
[TBL] [Abstract][Full Text] [Related]
9. Mutational and immunohistochemical analysis of ezrin-, radixin-, moesin (ERM) molecules in epilepsy-associated glioneuronal lesions.
Majores M; Schick V; Engels G; Fassunke J; Elger CE; Schramm J; Blümcke I; Becker AJ
Acta Neuropathol; 2005 Dec; 110(6):537-46. PubMed ID: 16231158
[TBL] [Abstract][Full Text] [Related]
10. Molecular neuropathology of epilepsy-associated glioneuronal malformations.
Becker AJ; Blümcke I; Urbach H; Hans V; Majores M
J Neuropathol Exp Neurol; 2006 Feb; 65(2):99-108. PubMed ID: 16462201
[TBL] [Abstract][Full Text] [Related]
11.
Kakkar A; Majumdar A; Pathak P; Kumar A; Kumari K; Tripathi M; Sharma MC; Suri V; Tandon V; Chandra SP; Sarkar C
Neurol India; 2017; 65(5):1076-1082. PubMed ID: 28879901
[TBL] [Abstract][Full Text] [Related]
12. Glioneuronal tumors of cerebral hemisphere in children: correlation of surgical resection with seizure outcomes and tumor recurrences.
Tomita T; Volk JM; Shen W; Pundy T
Childs Nerv Syst; 2016 Oct; 32(10):1839-48. PubMed ID: 27659827
[TBL] [Abstract][Full Text] [Related]
13. Expression of neurodegenerative disease-related proteins and caspase-3 in glioneuronal tumours.
Prabowo AS; Iyer AM; Veersema TJ; Anink JJ; Schouten-van Meeteren AY; Spliet WG; van Rijen PC; Ferrier CH; Thom M; Aronica E
Neuropathol Appl Neurobiol; 2015 Feb; 41(2):e1-e15. PubMed ID: 24750067
[TBL] [Abstract][Full Text] [Related]
14. Similar PDK1-AKT-mTOR pathway activation in balloon cells and dysmorphic neurons of type II focal cortical dysplasia with refractory epilepsy.
Lin YX; Lin K; Kang DZ; Liu XX; Wang XF; Zheng SF; Yu LH; Lin ZY
Epilepsy Res; 2015 May; 112():137-49. PubMed ID: 25847349
[TBL] [Abstract][Full Text] [Related]
15. Differential cellular gene expression in ganglioglioma.
Samadani U; Judkins AR; Akpalu A; Aronica E; Crino PB
Epilepsia; 2007 Apr; 48(4):646-53. PubMed ID: 17437409
[TBL] [Abstract][Full Text] [Related]
16. Evidence for mTOR pathway activation in a spectrum of epilepsy-associated pathologies.
Liu J; Reeves C; Michalak Z; Coppola A; Diehl B; Sisodiya SM; Thom M
Acta Neuropathol Commun; 2014 Jul; 2():71. PubMed ID: 25005575
[TBL] [Abstract][Full Text] [Related]
17. Evidence for developmental precursor lesions in epilepsy-associated glioneuronal tumors.
Blümcke I; Löbach M; Wolf HK; Wiestler OD
Microsc Res Tech; 1999 Jul; 46(1):53-8. PubMed ID: 10402272
[TBL] [Abstract][Full Text] [Related]
18. Gangliogliomas: an intriguing tumor entity associated with focal epilepsies.
Blümcke I; Wiestler OD
J Neuropathol Exp Neurol; 2002 Jul; 61(7):575-84. PubMed ID: 12125736
[TBL] [Abstract][Full Text] [Related]
19. FCD Type II and mTOR pathway: Evidence for different mechanisms involved in the pathogenesis of dysmorphic neurons.
Rossini L; Villani F; Granata T; Tassi L; Tringali G; Cardinale F; Aronica E; Spreafico R; Garbelli R
Epilepsy Res; 2017 Jan; 129():146-156. PubMed ID: 28056425
[TBL] [Abstract][Full Text] [Related]
20. Age at epilepsy onset in patients with focal cortical dysplasias, gangliogliomas and dysembryoplastic neuroepithelial tumours.
Rácz A; Müller AM; Schwerdt J; Becker A; Vatter H; Elger CE
Seizure; 2018 May; 58():82-89. PubMed ID: 29677585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
